Trial intelligence / Profile preview

Intra-articular hyaluronic acid versus corticosteroid injection for knee osteoarthritis

IRCT20210511051258N1Phase 3Completed

Sponsor
Vice Chancellor for Research, Birjand University of Medical Sciences
Start
Jul 2021
Countries
1
01

Overview

Phase 3, randomised, open-label trial of hyaluronic acid and corticosteroids in knee osteoarthritis (OA) and osteoarthritis (OA) (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoints: Visual analog scale score and WOMAC score. Started Jul 2021; status: completed.

02

Drugs

hyaluronic acidcorticosteroids
03

Conditions

knee osteoarthritis (OA)osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20210511051258N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210511051258N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call